Brown Brothers Harriman & CO Abiomed Inc Transaction History

Brown Brothers Harriman & CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $3,146 - $4,740	14 Added 0.93%	1,514 $375,000
Q2 2021 Aug 13, 2021	SELL	$262.71 - $351.17 $3,415 - $4,565	-13 Reduced 0.86%	1,500 $468,000
Q1 2021 May 13, 2021	BUY	$285.92 - $355.13 $3,716 - $4,616	13 Added 0.87%	1,513 $482,000
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $1,752 - $2,458	-11 Reduced 0.73%	1,500 $256,000
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $1,407 - $2,233	8 Added 0.53%	1,511 $269,000
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $752 - $854	3 Added 0.2%	1,503 $392,000
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $417,348 - $546,997	-1,510 Reduced 50.17%	1,500 $428,000
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $1,405 - $2,221	-5 Reduced 0.17%	3,010 $978,000
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $2,531 - $2,996	15 Added 0.5%	3,015 $565,000
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $12,067 - $13,993	-83 Reduced 2.69%	3,000 $506,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,083	3,083 $442,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.